Buscopan Compositum IV

Sodium Metamizole and butylhyoscine bromide injectable

Description

PDF Product Sheet BUSCOPAN COMPOSITUM INJ IV

Composition

Each ml contains:

Scopolamine butyl bromide

(Hyoscine butyl bromide)

4 mg
Metamizol sodium 500 mg
Characteristics

Scopolamine butyl bromide is an anti-cholinergic with affinity for the muscarine-receptors in smooth muscle cells of the gastro-intestinal-, bile- and urinary tracts, without having central effects. Metamizol sodium is a centrally acting analgesic and antipyretic. Combined, the substances have a strong spasmolytic effect.

Indications

Spasmodic colic, oesophageal obstruction, diarrhoea and uro-genital spasms.